ConductScience.org, home

Paper24907149

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.

Choy E and 4 others. Rheumatology (Oxford), 2014. Cited by 244 papers, by iCite.

Cite this record

ConductScience Library. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Papers, record 24907149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24907149

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
PubMed
Journal
Rheumatology (Oxford)
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
244
iCite
Relative citation ratio, by iCite
8.79
iCite
Revised in PubMed
2022-03-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Choy EErnest
2Ganeshalingam KKandeepan
3Semb AGAnne Grete
4Szekanecz ZZoltán
5Nurmohamed MMichael

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Cardiovascular DiseasesMajor topic
InflammationMajor topic
Antirheumatic Agents
Biological Products
Humans
Lipids
Risk Factors
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03960515Cardiovascular Profiles in Rheumatoid ArthritisBackgroundClinicalTrials.gov
NCT05938244Cardiac and Pulmonary Assessment in Egyptian Patients With Rheumatoid ArthritisBackgroundClinicalTrials.gov

Download CSV of trials

References148

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124368514Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.Ann Rheum Dis2015https://conductscience.org/library/papers/24368514PubMed
221360490
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year.
Arthritis Rheum2011https://conductscience.org/library/papers/21360490PubMed
320110520Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials.J Rheumatol2010https://conductscience.org/library/papers/20110520PubMed
412943870Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).Am J Cardiol2003https://conductscience.org/library/papers/12943870PubMed
512485966Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation2002https://conductscience.org/library/papers/12485966PubMed
623589412Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients.Arthritis Care Res (Hoboken)2013https://conductscience.org/library/papers/23589412PubMed
721843325Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.Arthritis Res Ther2011https://conductscience.org/library/papers/21843325PubMed
820551156Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study.Ann Rheum Dis2010https://conductscience.org/library/papers/20551156PubMed
922873531Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.N Engl J Med2012https://conductscience.org/library/papers/22873531PubMed
1019946022The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Rheumatology (Oxford)2010https://conductscience.org/library/papers/19946022PubMed
1123515142Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.Lancet2013https://conductscience.org/library/papers/23515142PubMed
1215742433Prediction of mortality in rheumatoid arthritis based on disease activity markers.J Rheumatol2005https://conductscience.org/library/papers/15742433PubMed
1318358926Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.Lancet2008https://conductscience.org/library/papers/18358926PubMed
1421884601Integrated safety in tocilizumab clinical trials.Arthritis Res Ther2011https://conductscience.org/library/papers/21884601PubMed
1519877093Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.Arthritis Rheum2009https://conductscience.org/library/papers/19877093PubMed
1619430165Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis.Circ J2009https://conductscience.org/library/papers/19430165PubMed
1719858120Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors.Rheumatology (Oxford)2009https://conductscience.org/library/papers/19858120PubMed
1812628952Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.Circulation2003https://conductscience.org/library/papers/12628952PubMed
1919035419Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.Arthritis Rheum2008https://conductscience.org/library/papers/19035419PubMed
2020957658Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis.Arthritis Care Res (Hoboken)2011https://conductscience.org/library/papers/20957658PubMed

See all 148 referencesDownload CSV of references

Cited by160

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.

PMIDTitleJournalYearIn PapersSource
42835576Autoimmune disorders and cardiovascular disease: a matched cross-sectional analysis of disease-specific associations in Qatari primary care.Am Heart J Plus2026https://conductscience.org/library/papers/42835576PubMed
42774336JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk?Front Pharmacol2026https://conductscience.org/library/papers/42774336PubMed
42684557
Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
Clin Rheumatol2026https://conductscience.org/library/papers/42684557PubMed
42683195Role of Cardiac Imaging in the Evaluation of Rheumatoid Arthiritis: A Systematic Analysis.Cureus2026https://conductscience.org/library/papers/42683195PubMed
42452709Comorbidity Profiles at Diagnosis in Rheumatoid Arthritis Versus Psoriatic Arthritis: A Nationwide Polish Claims-Based Study.J Clin Med2026https://conductscience.org/library/papers/42452709PubMed
42327968Oxidized High-Density Lipoprotein and Cardiovascular Risk in Rheumatoid Arthritis.J Clin Med Res2026https://conductscience.org/library/papers/42327968PubMed
42298194Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis.Nat Rev Rheumatol2026https://conductscience.org/library/papers/42298194PubMed
42291085Effect of IL-6 inhibition on lipoprotein(a) levels: A systematic review and meta-analysis.Am J Prev Cardiol2026https://conductscience.org/library/papers/42291085PubMed
42110040
Janus Kinase and Interleukin-6 Inhibitor-Induced Lipid Modulation and Its Association With Major Adverse Cardiovascular Events in Rheumatoid Arthritis: A Systematic Review of Clinical and Biomarker Evidence.
Cureus2026https://conductscience.org/library/papers/42110040PubMed
41727944Cardiovascular Disease and Risk Factors among Patients with Rheumatoid Arthritis in a Tertiary Government Hospital in the Philippines.Acta Med Philipp2026https://conductscience.org/library/papers/41727944PubMed
41346979Development and validation of an interpretable machine learning model for predicting low muscle mass in patients with rheumatoid arthritis: a multicenter study.Front Med (Lausanne)2025https://conductscience.org/library/papers/41346979PubMed
40943434Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis-A Narrative Review.Int J Mol Sci2025https://conductscience.org/library/papers/40943434PubMed
40918183Subclinical myocardial changes in rheumatoid arthritis: cardiovascular magnetic resonance evidence of immuno-inflammatory remodeling.Front Cardiovasc Med2025https://conductscience.org/library/papers/40918183PubMed
40794325Serum metabolomics identifies unique inflammatory signatures to distinguish rheumatoid arthritis responders and non-responders to TNF inhibitor therapy.Metabolomics2025https://conductscience.org/library/papers/40794325PubMed
40727925Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritis.J Circ Biomark2025https://conductscience.org/library/papers/40727925PubMed
40700294Survival Outcomes and Prognostic Factors in Rheumatoid Arthritis Patients Receiving Biologic or Targeted Synthetic Therapy: Real-World Data.Antibodies (Basel)2025https://conductscience.org/library/papers/40700294PubMed
40490834The impact of lifestyle modification on metabolic pathways in older adults with overweight/obesity and rheumatoid arthritis: a secondary exploratory analysis of the SWET-RA study.BMC Rheumatol2025https://conductscience.org/library/papers/40490834PubMed
40436519IL-6 Inhibitors and TNF Inhibitors: Impact on Exercise-induced Cardiac Adaptations in Patients With Rheumatoid Arthritis.JACC Basic Transl Sci2025https://conductscience.org/library/papers/40436519PubMed
40283183From Joints to the Heart: An Integrated Perspective on Systemic Inflammation.Life (Basel)2025https://conductscience.org/library/papers/40283183PubMed
40221560Clinical significance of the hemoglobin-to-red blood cell distribution width ratio in patients with severe OSAS.Sci Rep2025https://conductscience.org/library/papers/40221560PubMed

See all 160 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24907149

GET https://conductscience.org/api/papers/v1/24907149/references?page=2